Mylan launches generic Temodar capsules

PITTSBURGH — Mylan on Monday launched its generic of Temodar (temozolomide) capsules. The drug is indicated to treat newly diagnosed tumors called glioblastoma multiforme alongside radiotherapy and then as a maintenance treatment. 

 

Mylan’s temozolomide tablets will be available in 5-, 20-, 100-, 140-, 180- and 250-mg dosage strengths. The drug had U.S. sales of about $176.5 million for the 12 months ended May 31, according to IMS Health data.